| Autor: |
Zhongqin Gong, Minghui Wei, Vlantis, Alexander C., Chan, Jason Y. K., Van Hasselt, C. Andrew, Dongcai Li, Xianhai Zeng, Lingbin Xue, Tong, Michael C. F., Chen, George G. |
| Předmět: |
|
| Zdroj: |
Journal of Endocrinology; Apr2024, Vol. 261 Issue 1, p59-70, 12p |
| Abstrakt: |
The solute carrier (SLC) family is a large group of membrane transport proteins. Their dysfunction plays an important role in the pathogenesis of thyroid cancer. The most well-known SLC is the sodium-iodide symporter (NIS), also known as sodium/iodide co-transporter or solute carrier family 5 member 5 (SLC5A5) in thyroid cancer. The dysregulation of NIS in thyroid cancer is well documented. The role of NIS in the uptake of iodide is critical in the treatment of thyroid cancer, radioactive iodide (RAI) therapy in particular. In addition to NIS, other SLC members may affect the autophagy, proliferation, and apoptosis of thyroid cancer cells, indicating that an alteration in SLC members may affect different cellular events in the evolution of thyroid cancer. The expression of the SLC members may impact the uptake of chemicals by the thyroid, suggesting that targeting SLC members may be a promising therapeutic strategy in thyroid cancer. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
